Busy. Please wait.

Don't have an account? Sign up

taken

Age:

12 or younger
13 or older

Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account. Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password

Enter the email address associated with your account, and we'll email you a link to reset your password.

Upgrade to remove ads

Autonomic NS

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

Normal Size Small Size show me how

Created by: 12345678987654321000000

Popular Medical sets

Geneeskunde M1

Heelkunde M1

M1 beweging Groningen

Toetsvragen

Beweging

Electronic Health Record

NHA CBCS Exam

Medical roots

Doug Best's Medical Terminology On-Line Class - 2/09

toetsvragen opleiding Groningen

Medical Terminology: Root Words

Levenscyclus M1

Question	Answer
Sympathetic nervous system	Leaves spinal cord and synapse onto ganglion cells in paravertebral chain ganglia Originate in lateral grey matter Myelinated - preganglionic - white ramus Unmyelinated - postganglionic - grey ramus
Neurotransmitter in SNS	Preganglionic - Ach Postganglionic - NA except sweat glands
Varicosities	Bulbous structures on nerves contain storage granules Sequentially depolarises varicosities to release NA
Production of NA	Tyrosine - LDOPA by tyrosine hydroxylase LDOPA - dopamine by dopamine decarboxylase Dopamine - noradrenaline by dopamine beta hydroxylase Noradrenaline - adrenaline by Phenylethanolamin n-methyltransferase
Tyrosine hydroxylase	Tyrosine moved actively into the nerve varicosity by Na dependent aromatic L amino acid transporter A cytoplasmic enzyme that forms LDOPA Loosely associated with ER Fe and biopterin are cofactors
Regulation of tyrosine hydroxylase	Acute regulation; noradrenaline competes for biopterin binding site to reduce activity Longer term up regulation by de novo synthesis Can also be inhibited by phosphorylation
Dopamine beta hydroxylase	Located in storage vesicles Specificity not hight so will convert many phenylethylamine derivatives e.g. octopamine from tyramine Ascorbate is a cofactor
PNMT	Located in chromaffin cells of the adrenal medulla Also converts other hydroxylated phenylethylamines e.g. synephrine from octopamine
Alpha methyltyrosine	inhibits tyrosine hydroxylase A competitive inhibitor Higher affinity that tyrosine Reduces amount of transmitter
Carbidopa	Inhibits dopa decarboxylase A peripheral inhibitor of dopa decarboxylase Reduces peripheral side effects and effective dose in LDOPA therapy
Disulfiram	Inhibits dopamine beta hydroxylase Reduces noradrenalin synthesis Clinical use as an inhibitor of aldehyde dehydrogenase - used in alcoholism
LDOPA	Bypass tyrosine hydroxylase Increases dopamine/noradrenaline/adrenaline synthesis Increases brain dopamine in parkinsons
False transmitters	Alpha methyl dopa is converted to alpha methyldopamine and aplha methylnoradrenaline by normal enzymes Stored and released as a false transmitter Binds to alpha 2 receptors and down regulated secretion of noradrenaline - decreases vasoconstriction
Storage of noradrenaline	Hight conc of noradrenaline in cytoplasmic vesicles Bound along with ATP and chromogranin A Transported into vesicle by VMAT2 Driven by proton gradient set up by ATP dependent H pump
Reserpine	Binds to amine binding site to block uptake and deplete stored NA due to leak from vesicle Acts in periphery and brain Previously used as an antihypertensive Leads to depression due to activity on CNS 5-HT
Adrenergic neuron blocking drugs	Carried into nerve by uptake 1 - may potentiate exogenous NA Low doses - block release of NA by APs, mechanism may involve hyperpolarisation of nerve ending High doses - indirectly acting sympathomimetic effect
Presynaptic auto receptors	All sympathetic nerve ending express alpha2 adrenoreceptors NA activates and reduces release Can also have other receptors e.g. Beta 2. opioid and M2
Indirectly acting sympathomimetics	Increase NA release e.g. tyramine and amphetamines
Termination of NA effects	Uptake 1 - norepinephrine transporter - on presynaptic nerve terminals to recycle NA Uptake 2 - extra neural monoamine transporter - on postsynaptic cells for uptake and metabolism Diffusion - transmitter carried to liver for metabolism
NA uptake into cells	Uptake 1 - 12 transmembrane domain NET, Na dependent and blocked by cocaine and tricyclic antidepressants Uptake 2 - ENT, not Na dependent and can also carry dopamine and other amines, blocked by corticosteroids
Monoamine oxidase	Found in outer mitochondrial membrane and extracellularly Metabolise catecholamines, 5-HT, DA, histamine etc Neuronal MAO maintains low cytoplasmic NA MAO-A - NA, Adr, DA, 5-HT MAO-B - %-HT, DA and trace amines
Monoamine oxidase inhibitors	MAO-A - Clorgiline used in depression MAO-B - Selegiline in parkinsons Both - tranylcypromine in depression
Catechol O-methyl transferase	Cytoplasmic enzyme found in liver, kidney and other tissues Most NA and Adr in circulation is metabolised by COMT Often associated with uptake 2 Inhibited by entacapone (used in parkinsons)